A Two-Way Interaction Study Between RO5190591/RTV and Ketoconazole in Healthy Subjects.

Trial Profile

A Two-Way Interaction Study Between RO5190591/RTV and Ketoconazole in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Danoprevir (Primary) ; Ketoconazole; Ritonavir
  • Indications Hepatitis C; HIV infections
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 18 Apr 2012 Planned End Date changed to 1 Nov 2010, according to ClinicalTrials.gov record.
    • 18 Apr 2012 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
    • 23 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top